Illumina (WBO:ILMN) EV-to-Revenue

: 4.57 (As of Today)

View and export this data going back to 2017. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Illumina's enterprise value is €19,108 Mil. Illumina's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €4,178 Mil. Therefore, Illumina's EV-to-Revenue for today is 4.57.

The historical rank and industry rank for Illumina's EV-to-Revenue or its related term are showing as below:

WBO:ILMN' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.64 Med: 12.17 Max: 22.58
Current: 4.52

During the past 13 years, the highest EV-to-Revenue of Illumina was 22.58. The lowest was 3.64. And the median was 12.17.

WBO:ILMN's EV-to-Revenue is ranked worse than
63% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.03 vs WBO:ILMN: 4.52

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-23), Illumina's stock price is €111.30. Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €26.44. Therefore, Illumina's PS Ratio for today is 4.21.

Illumina EV-to-Revenue Historical Data

The historical data trend for Illumina's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

13.33

16.19

13.46

7.30

5.18

Illumina Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															7.30	8.61	6.97	5.18	5.18

Competitive Comparison

For the Diagnostics & Research subindustry, Illumina's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Illumina EV-to-Revenue Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Illumina's EV-to-Revenue falls into.

Illumina EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Illumina's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	19108.280	/	4178.083
	=	4.57

Illumina's current Enterprise Value is €19,108 Mil.
Illumina's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €4,178 Mil.

Illumina (WBO:ILMN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Illumina's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	111.30	/	26.444
	=	4.21

Illumina's share price for today is €111.30.
Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €26.44.

Illumina EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Illumina's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (WBO:ILMN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (WBO:ILMN) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.